In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Uwe Zeymer
Speaker
Uwe Zeymer

Klinikum Ludwigshafen, Ludwigshafen (Germany)

Specialities : Interventional Cardiology , Acute Cardiac Care, Acute Coronary Syndromes

41 presentations from this speaker

Incidence and prognostic impact of sepsis in patients with acute myocardial infarction complicated by cardiogenic shock - Results of the CULPRIT-SHOCK study and registry

Congress : ESC Congress 2019

  • Session : Assessment and management of patients with myocardial infraction and shock
  • Speaker : U Zeymer (Ludwigshafen,DE)

Myocardial revascularisation in patients with cardiogenic shock.- What do the Guidelines say.

Congress : Acute Cardiovascular Care 2019

  • Session : Myocardial revascularisation guidelines tested by reality
  • Speaker : U Zeymer (Ludwigshafen,DE)

Use of the IMPELLA mechanical support device in patients with acute myocardial infarction complicated by cardiogenic shock - Results of the CULPRIT-SHOCK trial

Congress : ESC Congress 2019

  • Session : Mechanical circulatory support in acute coronary syndromes : are we turning in circles ?
  • Speaker : U Zeymer (Ludwigshafen,DE)

All patients without ST elevation but with troponin elevation after CPR should undergo urgent coronary angiography - CONTRA.

Congress : Acute Cardiovascular Care 2018

  • Session : Controversies in patients with NSTEMI
  • Speaker : U Zeymer (Ludwigshafen,DE)

Characteristics of heart failure patients treated with Sacubitril - Valsartan in Europe. Results from ARIADNE

Congress : ESC Congress 2018

  • Session : Chronic heart failure - Treatment
  • Speaker : U Zeymer (Ludwigshafen,DE)

Impact of pre-hospital resuscitation on short-and long-term mortality in patients with cardiogenic shock undergoing revascularization. Results of the IABP-SHOCK study.

Congress : ESC Congress 2018

  • Session : Cardiogenic shock following myocardial infarction: beyond the mechanics
  • Speaker : U Zeymer (Ludwigshafen,DE)

Revascularisation in cardiogenic shock

Congress : ESC Congress 2018

  • Session : Management of cardiogenic shock in acute coronary syndromes - The "Shock Team" at work
  • Speaker : U Zeymer (Ludwigshafen,DE)

The ACCA-EAPCI registry on ST-elevation myocardial infarction of the European Society of Cardiology (ESC)

Congress : ESC Congress 2018

  • Session : ESC/EORP Late Breaking Registry Results
  • Speaker : U Zeymer (Ludwigshafen,DE)

What is the optimal timing of administration of P2Y12 inhibitor in STEMI?

Congress : Acute Cardiovascular Care 2018

  • Session : Optimisation of STEMI treatment
  • Speaker : U Zeymer (Ludwigshafen,DE)

How representive is the PARADIGM heart failure population ?

Congress : ESC Congress 2017

  • Session : Acute heart failure (AHF)
  • Speaker : U Zeymer (Ludwigshafen,DE)

Rationale and design of ARIADNE. assessment of real life care describing european heart failure management

Congress : Heart Failure 2017

  • Session : Chronic heart failure
  • Speaker : U Zeymer (Ludwigshafen,DE)

The role of revascularisation.

Congress : Acute Cardiovascular Care 2016

  • Session : Cardiogenic shock
  • Speaker : U Zeymer (Ludwigshafen,DE)

All patients with STEMI should receive bivalirudin at first medical contact: PRO.

Congress : Acute Cardiovascular Care 2015

  • Session : Optimal choice and timing of antithrombotic therapy in ACS
  • Speaker : U Zeymer (Ludwigshafen,DE)

Prognosis and risk prediction.

Congress : Acute Cardiovascular Care 2015

  • Session : Update in NSTE-ACS
  • Speaker : U Zeymer (Ludwigshafen,DE)

Risk assessment: bleeding versus thrombosis.

Congress : ESC Congress 2015

  • Session : Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome
  • Speaker : U Zeymer (Ludwigshafen,DE)

Risk prediction of patients with and without acute coronary syndrome.

Congress : Heart Failure 2015

  • Session : Cardiogenic shock: how can we improve prognosis?
  • Speaker : U Zeymer (Ludwigshafen,DE)

Culprit lesion only PCI or complete revascularisation in patients with multivessel disease.

Congress : ESC Congress 2014

  • Session : STEMI complicated by cardiogenic shock
  • Speaker : U Zeymer (Ludwigshafen,DE)

Optimal revascularisation: the jury is still out.

Congress : ESC Congress 2014

  • Session : Management of cardiogenic shock related to acute coronary syndromes
  • Speaker : U Zeymer (Ludwigshafen,DE)

Optimal timing of coronary angiography.

Congress : ESC Congress 2014

  • Session : Optimising outcomes after prehospital resuscitation
  • Speaker : U Zeymer (Ludwigshafen,DE)

Contra.

Congress : ESC Congress 2013

  • Session : Every patient with non ST-elevation myocardial infarction should go direct to the cath lab.
  • Speaker : U Zeymer (Ludwigshafen,DE)

Contra.

Congress : ESC Congress 2013

  • Session : Every patient with non ST-elevation myocardial infarction should go direct to the cath lab.
  • Speaker : U Zeymer (Ludwigshafen,DE)

Differences in incidence of hospital admissions for acute coronary syndromes in five Western countries

Congress : ESC Congress 2013

  • Session : Infarction acute phase non STEMI
  • Speaker : U Zeymer (Ludwigshafen,DE)

How to track patients who will develop further events.

Congress : ESC Congress 2013

  • Session : The future of anti-thrombotic therapy: reducing long term risk in patients with myocardial infarction
  • Speaker : U Zeymer (Ludwigshafen,DE)
  • Sponsored by MSD

Pretreatment with prasugrel is safe and associated with an improvement outcome in patients with NSTE-ACS

Congress : ESC Congress 2013

  • Session : Thrombosis and antithrombotic therapy
  • Speaker : U Zeymer (Ludwigshafen,DE)

Quality indicators for acute coronary angioplasty: is it feasible?

Congress : ESC Congress 2013

  • Session : Quality indicators for acute cardiac care
  • Speaker : U Zeymer (Ludwigshafen,DE)

Members get more

Join now
  • 1ESC Professional Members – access all resources from ESC Congress and ESC Asia with APSC & AFC
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s congress resources
  • 3Under 40 or in training - with a Combined Membership, access resources from all congresses
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are